| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $-0.04 (Beat by $0.35) |
| EPS GAAP Actual | $-0.04 (Beat by $0.35) |
| Revenue Actual | $0.460135B |
| Revenue Surprise | Beat by $460.135M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.2873 |
| EPS GAAP Estimate | $1.2873 |
| Revenue Estimate | $0.819517506B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 2.15 | 6.45 | 2.12811 | 2.17223 | 1 |
| Sep 2028 | 2.1543 | 6.43 | 2.11703 | 2.18176 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -6.9 | -6.9 | 0.460135B | 17.88% | 460.14M |
| FQ2 2025 (Jun 2025) | 0.66 | 0.66 | 0.552864B | 1.89% | 552.86M |
| FQ1 2025 (Mar 2025) | -0.02 | -0.02 | 0.483521B | -0.99% | 483.52M |
| FQ4 2024 (Dec 2024) | -0.81 | -0.81 | 0.375814B | 3.14% | 375.81M |
| FQ3 2024 (Sep 2024) | -0.634 | -0.634 | 0.377855B | -19.35% | 377.86M |
| FQ4 2017 (Dec 2017) | -110.66 | -110.66 | 0.110826B | 100% | 110.83M |
| FQ1 2018 (Mar 2018) | -110.66 | -110.66 | 0.110826B | 100% | 110.83M |
| FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 0.542441B | 100% | 542.44M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.2873
Consensus Revenue Estimates
0.819517506B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.31 | -- | 1.27439 | 1.34127 | 1 |
| FQ1 2028 (Mar 2028) | 0.56 | -- | 0.54478 | 0.57337 | 1 |
| FQ4 2027 (Dec 2027) | -0.31 | -- | -0.3174 | -0.30157 | 1 |
| FQ2 2027 (Jun 2027) | 2.54 | -- | 2.43883 | 2.67063 | 3 |
| FQ1 2027 (Mar 2027) | 1.24 | -- | 1.19061 | 1.30377 | 3 |
| FQ4 2026 (Oct 2026) | 1.259 | -- | 1.24622 | 1.26942 | 0 |
| FQ3 2026 (Jul 2026) | 2.8955 | 338.3 | 2.86611 | 2.91946 | 0 |
| FQ2 2026 (Jun 2026) | 2.8955 | 77.21 | 2.78492 | 3.07236 | 3 |
| FQ1 2026 (Mar 2026) | 1.2873 | 101.55 | 1.23814 | 1.36593 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 0.59B | -- | 0.57B | 0.6B | 1 |
| FQ1 2028 (Mar 2028) | 0.51B | -- | 0.49B | 0.51B | 1 |
| FQ4 2027 (Dec 2027) | 0.39B | -- | 0.38B | 0.4B | 2 |
| FQ2 2027 (Jun 2027) | 0.62B | -- | 0.6B | 0.65B | 4 |
| FQ1 2027 (Mar 2027) | 0.53B | -- | 0.51B | 0.55B | 4 |
| FQ4 2026 (Oct 2026) | 0.88B | -- | 0.87B | 0.89B | 2 |
| FQ3 2026 (Jul 2026) | 0.83B | 44.57 | 0.82B | 0.84B | 2 |
| FQ2 2026 (Jun 2026) | 0.87B | 36.4 | 0.84B | 0.91B | 4 |
| FQ1 2026 (Mar 2026) | 0.82B | 41 | 0.8B | 0.86B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -6.9 | -6.9 | 100% | |
| FQ2 2025 (Jun 2025) | 0.66 | 0.66 | 100% | |
| FQ1 2025 (Mar 2025) | -0.02 | -0.02 | 100% | |
| FQ4 2024 (Dec 2024) | -0.81 | -0.81 | 100% | |
| FQ3 2024 (Sep 2024) | -0.634 | -0.634 | 100% | |
| FQ4 2017 (Dec 2017) | -110.66 | -110.66 | 100% | |
| FQ1 2018 (Mar 2018) | -110.66 | -110.66 | 100% | |
| FQ2 2024 (Jun 2024) | 1.01 | 1.01 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.46B | $460.14M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.55B | $552.86M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.48B | $483.52M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.38B | $375.81M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.38B | $377.86M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0.11B | $110.83M | 100% |
| FQ1 2018 (Mar 2018) | $0B | $0.11B | $110.83M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.54B | $542.44M | 100% |